Literature DB >> 7961975

Determination of the G beta gamma-binding domain of phosducin. A regulatable modulator of G beta gamma signaling.

B E Hawes1, K Touhara, H Kurose, R J Lefkowitz, J Inglese.   

Abstract

Although a role for the beta gamma-subunits of heterotrimeric G proteins (G beta gamma) in signal transduction by several cellular systems has been established, the structural features of cellular proteins interacting with G beta gamma have yet to be fully elucidated. The G beta gamma-binding region of beta-adrenergic receptor kinase (beta ARK), a cytosolic enzyme recruited to the membrane receptor substrate by G beta gamma, has been localized to the carboxyl terminus of the enzyme. Here, we demonstrate that the amino terminus of phosducin, a 33-kDa G beta gamma-binding retinal phosphoprotein, contains sequences homologous with the G beta gamma-binding domain of beta ARK. Accordingly, a glutathione S-transferase-fusion protein containing only the amino-terminal 105 amino acids of phosducin displayed G beta gamma binding ability. This domain of phosducin contains a protein kinase A (PKA) phosphorylation site, and upon phosphorylation, the binding of full-length phosducin to G beta gamma is reduced. In addition, transient expression of phosducin in COS-7 cells significantly inhibits G beta gamma-mediated phosphoinositide hydrolysis. This inhibitory effect is completely reversed by pretreatment of cells with dibutyryl cAMP, an activator of PKA. Thus, the binding of G beta gamma to phosducin can be regulated by PKA-phosphorylation in an intact cell model system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961975

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.

Authors:  H LeVine
Journal:  Mol Neurobiol       Date:  1999-04       Impact factor: 5.590

2.  Modulation of CRX transactivation activity by phosducin isoforms.

Authors:  X Zhu; C M Craft
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

3.  A small region in phosducin inhibits G-protein betagamma-subunit function.

Authors:  K Blüml; W Schnepp; S Schröder; M Beyermann; M Macias; H Oschkinat; M J Lohse
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

4.  The phosducin-like protein PhLP1 is essential for G{beta}{gamma} dimer formation in Dictyostelium discoideum.

Authors:  Jaco C Knol; Ruchira Engel; Mieke Blaauw; Antonie J W G Visser; Peter J M van Haastert
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  Inhibition of G-protein betagamma-subunit functions by phosducin-like protein.

Authors:  S Schröder; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

6.  Structure of the complex between the cytosolic chaperonin CCT and phosducin-like protein.

Authors:  Jaime Martín-Benito; Sara Bertrand; Ting Hu; Paul J Ludtke; Joseph N McLaughlin; Barry M Willardson; José L Carrascosa; José M Valpuesta
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

7.  Phosducin is a ubiquitous G-protein regulator.

Authors:  S Danner; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Regulation of phosducin phosphorylation in retinal rods by Ca2+/calmodulin-dependent adenylyl cyclase.

Authors:  B M Willardson; J F Wilkins; T Yoshida; M W Bitensky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

Review 9.  Function of phosducin-like proteins in G protein signaling and chaperone-assisted protein folding.

Authors:  Barry M Willardson; Alyson C Howlett
Journal:  Cell Signal       Date:  2007-06-28       Impact factor: 4.315

10.  The N terminus of phosducin is involved in binding of beta gamma subunits of G protein.

Authors:  J Xu; D Wu; V Z Slepak; M I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.